Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone and 11ß-HSD1 in Metabolic Syndrome
NCT00370305Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- May 2004
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in metabolic syndrome, impaired glucose tolerance (IGT), sponsored by Charité – Universitätsmedizin Berlin. Started May 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
metabolic syndromeimpaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00370305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370305.